Cargando…
Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology
Cancer immunotherapy utilizes the immune system to fight cancer and has already moved from the laboratory to clinical application. However, and despite excellent therapeutic outcomes in some hematological and solid cancers, the regular clinical use of cancer immunotherapies reveals major limitations...
Autores principales: | Bockamp, Ernesto, Rosigkeit, Sebastian, Siegl, Dominik, Schuppan, Detlef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565449/ https://www.ncbi.nlm.nih.gov/pubmed/32942725 http://dx.doi.org/10.3390/cells9092102 |
Ejemplares similares
-
A PCR protocol to establish standards for routine mycoplasma testing that by design detects over ninety percent of all known mycoplasma species
por: Siegl, Dominik, et al.
Publicado: (2023) -
Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
por: Foerster, Friedrich, et al.
Publicado: (2017) -
Nanotechnology-enhanced immunotherapy for metastatic cancer
por: Zhang, Peisen, et al.
Publicado: (2021) -
RNA Nanotechnology-Mediated Cancer Immunotherapy
por: Lin, Yao-Xin, et al.
Publicado: (2020) -
Nanotechnology-based products for cancer immunotherapy
por: Shams, Forough, et al.
Publicado: (2021)